| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |